Specify a stock or a cryptocurrency in the search bar to get a summary
Cellsource Co Ltd
4880CellSource Co., Ltd. engages in the regenerative medicine-related businesses in Japan. The company provides processing services to extract adipose-derived stem cells from patients' adipose tissues, and to prepare platelet-rich plasma from patients' blood; and offers support services for medical facilities providing regenerative medicine therapy, as well as manufacturing processed cells. It is also involved in the development and sale of Signalift series of anti-aging products, including a serum. The company was incorporated in 2015 and is headquartered in Tokyo, Japan. Address: SHIBUYA CAST., Tokyo, Japan, 150-0002
Analytics
WallStreet Target Price
250 577.6 JPYP/E ratio
27.9271Dividend Yield
0.44 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 4880
Dividend Analytics 4880
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
31 %Dividend History 4880
Stock Valuation 4880
Financials 4880
Results | 2019 | Dynamics |